Impact of dupilumab discontinuation in a patient with atopic prurigo
Nicola Milanesi(Ospedale del Ceppo), Filomena Russo(University of Siena), Greta Tronconi(University of Florence), Massimo Gola(University of Florence), Maria Laura Flori(University of Siena)
Cited by 0
Related Papers
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment
|BioMed Research International|2014|69
Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience
|Journal of the European Academy of Dermatology and Venereology|2022|60
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry
|Allergy|2021|37
Contact sensitivity to 2‐hydroxyethyl methacrylate in consecutive patients: A 1‐year multicentre SIDAPA study
|Contact Dermatitis|2019|27
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy
|British Journal of Dermatology|2014|23